Ácido Tranexâmico no Traumatismo Cranioencefálico (CRASH-3 Trial): já é hora de atualizar nossa conduta? Leia mais »
CRASH-3 (Trial) Lancet 2019 – Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial The CRASH-3 trial collaborators† Show footnotesOpen AccessPublished:October 14, 2019DOI:https://doi.org/10.1016/S0140-6736(19)32233-0 Leia mais »
Intraoperative contrast-enhanced ultrasound for cerebral glioma resection and the relationship between microvascular perfusion and microvessel density. Leia mais »
Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study Leia mais »
Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis Leia mais »
Treatment strategy and long-term outcomes of primary intracranial rhabdomyosarcoma: a single-institution experience and systematic review. Leia mais »
